Universal Health (UHS) Stock Forecast, Price Targets and Analysts Predictions

UHS Analyst Ratings

Hold

4 Buy

8 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Universal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

―

Based on 13 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is CHF154.22 with a high forecast of CHF231.73 and a low forecast of CHF132.64. The average price target represents a ― change from the last price of ―.

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

Highest Price TargetCHF231.73

Average Price TargetCHF154.22

Lowest Price TargetCHF132.64

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ben Hendrix

RBC Capital

CHF146.23

Hold

―

Reiterated

08/19/26

RBC Capital Sticks to Its Hold Rating for Universal Health (UHS)

Kevin Fischbeck

Bank of America Securities

CHF129.45→CHF135.84

Sell

―

Reiterated

08/10/26

Bank of America Securities Sticks to Their Sell Rating for Universal Health (UHS)

Stephen Baxter

Wells Fargo

CHF132.64

Hold

―

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), BridgeBio Pharma (NASDAQ: BBIO) and Universal Health (NYSE: UHS)

Scott Fidel

Goldman Sachs

CHF193.37→CHF151.82

Hold

―

Assigned

07/30/26

Universal Health price target lowered to $190 from $242 at Goldman SachsUniversal Health price target lowered to $190 from $242 at Goldman Sachs

A.J. Rice

UBS

CHF247.71→CHF231.73

Buy

―

Reiterated

07/29/26

Universal Health price target lowered to $290 from $310 at UBSUniversal Health price target lowered to $290 from $310 at UBS

Craig Hettenbach

Morgan Stanley

CHF169.4→CHF152.62

Hold

―

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: Haemonetics (NYSE: HAE), Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Universal Health (NYSE: UHS)

Ryan Langston

TD Cowen

CHF157.42

Buy

―

Assigned

07/29/26

TD Cowen Reaffirms Their Buy Rating on Universal Health (UHS)

Michael Ha

Robert W. Baird

CHF163.01→CHF132.64

Hold

―

Reiterated

07/29/26

Universal Health price target lowered to $166 from $204 at BairdUniversal Health price target lowered to $166 from $204 at Baird

Sarah James

Cantor Fitzgerald

CHF155.02

Hold

―

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), Insmed (NASDAQ: INSM) and Edwards Lifesciences (NYSE: EW)

Jason Cassorla

Guggenheim

CHF155.82→CHF151.02

Buy

―

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Incyte (INCY)

Andrew Mok CFA

Barclays

CHF143.03→CHF134.24

Hold

―

Reiterated

07/28/26

Barclays Sticks to Its Hold Rating for Universal Health (UHS)

Ann Hynes

Mizuho Securities

CHF183.78→CHF159.81

Buy

―

Reiterated

07/13/26

Mizuho Securities Sticks to Their Buy Rating for Universal Health (UHS)

Benjamin Rossi

J.P. Morgan

CHF187.78→CHF163.81

Hold

―

Reiterated

05/22/26

J.P. Morgan Keeps Their Hold Rating on Universal Health (UHS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ben Hendrix

RBC Capital

CHF146.23

Hold

―

Reiterated

08/19/26

RBC Capital Sticks to Its Hold Rating for Universal Health (UHS)

Kevin Fischbeck

Bank of America Securities

CHF129.45→CHF135.84

Sell

―

Reiterated

08/10/26

Bank of America Securities Sticks to Their Sell Rating for Universal Health (UHS)

Stephen Baxter

Wells Fargo

CHF132.64

Hold

―

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), BridgeBio Pharma (NASDAQ: BBIO) and Universal Health (NYSE: UHS)

Scott Fidel

Goldman Sachs

CHF193.37→CHF151.82

Hold

―

Assigned

07/30/26

Universal Health price target lowered to $190 from $242 at Goldman SachsUniversal Health price target lowered to $190 from $242 at Goldman Sachs

A.J. Rice

UBS

CHF247.71→CHF231.73

Buy

―

Reiterated

07/29/26

Universal Health price target lowered to $290 from $310 at UBSUniversal Health price target lowered to $290 from $310 at UBS

Craig Hettenbach

Morgan Stanley

CHF169.4→CHF152.62

Hold

―

Reiterated

07/29/26

Analysts Conflicted on These Healthcare Names: Haemonetics (NYSE: HAE), Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Universal Health (NYSE: UHS)

Ryan Langston

TD Cowen

CHF157.42

Buy

―

Assigned

07/29/26

TD Cowen Reaffirms Their Buy Rating on Universal Health (UHS)

Michael Ha

Robert W. Baird

CHF163.01→CHF132.64

Hold

―

Reiterated

07/29/26

Universal Health price target lowered to $166 from $204 at BairdUniversal Health price target lowered to $166 from $204 at Baird

Sarah James

Cantor Fitzgerald

CHF155.02

Hold

―

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), Insmed (NASDAQ: INSM) and Edwards Lifesciences (NYSE: EW)

Jason Cassorla

Guggenheim

CHF155.82→CHF151.02

Buy

―

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Incyte (INCY)

Andrew Mok CFA

Barclays

CHF143.03→CHF134.24

Hold

―

Reiterated

07/28/26

Barclays Sticks to Its Hold Rating for Universal Health (UHS)

Ann Hynes

Mizuho Securities

CHF183.78→CHF159.81

Buy

―

Reiterated

07/13/26

Mizuho Securities Sticks to Their Buy Rating for Universal Health (UHS)

Benjamin Rossi

J.P. Morgan

CHF187.78→CHF163.81

Hold

―

Reiterated

05/22/26

J.P. Morgan Keeps Their Hold Rating on Universal Health (UHS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months

Whit MayoLeerink Partners

Success Rate

21/31 ratings generated profit

Average Return

+4.51%

Copying Whit Mayo's trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +4.51% per trade.

1 Year

Ann HynesMizuho Securities

Success Rate

20/27 ratings generated profit

Average Return

+11.35%

Copying Ann Hynes's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +11.35% per trade.

2 Years

Ann HynesMizuho Securities

Success Rate

22/27 ratings generated profit

Average Return

+24.07%

Copying Ann Hynes's trades and holding each position for 2 Years would result in 81.48% of your transactions generating a profit, with an average return of +24.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

3

2

1

Buy

9

6

7

5

Hold

10

12

9

13

12

Sell

2

3

4

Strong Sell

0

total

24

23

21

24

22

In the current month, UHS has received 6 Buy Ratings, 12 Hold Ratings, and 4 Sell Ratings. UHS average Analyst price target in the past 3 months is 154.22.

Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is CHF4.22 with a range of CHF3.31 to CHF4.74. The previous quarter’s EPS was CHF4.78. UHS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Sales Forecast

Next quarter’s sales forecast for UHS is CHF3.77B with a range of CHF3.65B to CHF3.87B. The previous quarter’s sales results were CHF3.71B. UHS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Stock Forecast FAQ

What is CH:UHS’s average 12-month price target, according to analysts?

Based on analyst ratings, Universal Health’s 12-month average price target is 154.22.

What is CH:UHS’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:UHS, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Universal Health a Buy, Sell or Hold?

Universal Health has a consensus rating of Hold, which is based on 4 buy ratings, 8 hold ratings and 1 sell ratings.

What is Universal Health’s share price target?

The average share price target for Universal Health is 154.22. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF231.73 ,and the lowest forecast is CHF132.64. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Universal Health?

Universal Health’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Universal Health?

To buy shares of CH:UHS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Universal Health (UHS) Stock Forecast & Price Target

UHS Analyst Ratings

UHS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Universal Health

UHS Analyst Recommendation Trends

UHS Financial Forecast

UHS Earnings Forecast

UHS Sales Forecast

UHS Stock Forecast FAQ

Detailed List of Analyst Forecasts